BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 34093829)

  • 1. Hereditary cancer syndrome-associated pathogenic variants are common in patients with hematologic malignancies subsequent to primary solid cancer.
    Oh J; Kim YR; Kim Y; Kim B; Park KS; Nam SH; Lee KA
    J Cancer; 2021; 12(14):4288-4294. PubMed ID: 34093829
    [No Abstract]   [Full Text] [Related]  

  • 2. Clonal haemopoiesis and therapy-related myeloid malignancies in elderly patients: a proof-of-concept, case-control study.
    Gillis NK; Ball M; Zhang Q; Ma Z; Zhao Y; Yoder SJ; Balasis ME; Mesa TE; Sallman DA; Lancet JE; Komrokji RS; List AF; McLeod HL; Alsina M; Baz R; Shain KH; Rollison DE; Padron E
    Lancet Oncol; 2017 Jan; 18(1):112-121. PubMed ID: 27927582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improving the detection of patients with inherited predispositions to hematologic malignancies using next-generation sequencing-based leukemia prognostication panels.
    DiNardo CD; Routbort MJ; Bannon SA; Benton CB; Takahashi K; Kornblau SM; Luthra R; Kanagal-Shamanna R; Medeiros LJ; Garcia-Manero G; M Kantarjian H; Futreal PA; Meric-Bernstam F; Patel KP
    Cancer; 2018 Jul; 124(13):2704-2713. PubMed ID: 29682723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Approach Toward Germline Predisposition Syndromes in Patients with Hematologic Malignancies.
    Atluri H; Gerstein YS; DiNardo CD
    Curr Hematol Malig Rep; 2022 Dec; 17(6):275-285. PubMed ID: 36279069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple Primary Cancers With Hematologic Malignancies and Germline Predisposition: A Case Series.
    Yun J; Lee DS; Lee S; Yun H
    Ann Lab Med; 2024 Sep; 44(5):446-449. PubMed ID: 38449380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinction of lymphoid and myeloid clonal hematopoiesis.
    Niroula A; Sekar A; Murakami MA; Trinder M; Agrawal M; Wong WJ; Bick AG; Uddin MM; Gibson CJ; Griffin GK; Honigberg MC; Zekavat SM; Paruchuri K; Natarajan P; Ebert BL
    Nat Med; 2021 Nov; 27(11):1921-1927. PubMed ID: 34663986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Germline Predisposition in Hematologic Malignancies: Testing, Management, and Implications.
    Godley LA; DiNardo CD; Bolton K
    Am Soc Clin Oncol Educ Book; 2024 Jun; 44(3):e432218. PubMed ID: 38768412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Precision Medicine in Children and Young Adults with Hematologic Malignancies and Blood Disorders: The Columbia University Experience.
    Marks LJ; Oberg JA; Pendrick D; Sireci AN; Glasser C; Coval C; Zylber RJ; Chung WK; Pang J; Turk AT; Hsiao SJ; Mansukhani MM; Glade Bender JL; Kung AL; Sulis ML
    Front Pediatr; 2017; 5():265. PubMed ID: 29312904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Li-Fraumeni syndrome: not a straightforward diagnosis anymore-the interpretation of pathogenic variants of low allele frequency and the differences between germline PVs, mosaicism, and clonal hematopoiesis.
    Batalini F; Peacock EG; Stobie L; Robertson A; Garber J; Weitzel JN; Tung NM
    Breast Cancer Res; 2019 Sep; 21(1):107. PubMed ID: 31533767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomic Landscape of Patients with Germline
    Yu K; Deuitch N; Merguerian M; Cunningham L; Davis J; Bresciani E; Diemer J; Andrews E; Young A; Donovan F; Sood R; Craft K; Chong S; Chandrasekharappa S; Mullikin J; Liu PP
    bioRxiv; 2023 Jan; ():. PubMed ID: 36789433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beyond Pathogenic
    Förster A; Decker M; Schlegelberger B; Ripperger T
    Cancers (Basel); 2022 Jul; 14(14):. PubMed ID: 35884491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased Frequency of Clonal Hematopoiesis of Indeterminate Potential in Bloom Syndrome Probands and Carriers.
    Lin I; Wei A; Gebo TA; Boutros PC; Flanagan M; Kucine N; Cunniff C; Arboleda VA; Chang VY
    medRxiv; 2024 Feb; ():. PubMed ID: 38370823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Germline and somatic drivers in inherited hematologic malignancies.
    Zoller J; Trajanova D; Feurstein S
    Front Oncol; 2023; 13():1205855. PubMed ID: 37904876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidental findings from cancer next generation sequencing panels.
    Maani N; Panabaker K; McCuaig JM; Buckley K; Semotiuk K; Farncombe KM; Ainsworth P; Panchal S; Sadikovic B; Armel SR; Lin H; Kim RH
    NPJ Genom Med; 2021 Jul; 6(1):63. PubMed ID: 34282142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer predisposition syndromes associated with myeloid malignancy.
    Quinn E; Nichols KE
    Semin Hematol; 2017 Apr; 54(2):115-122. PubMed ID: 28637615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inherited DNA repair gene mutations detected by tumor next generation sequencing in urinary tract cancers.
    Gupta S; Greenberg S; Grimmett J; Gaston D; Agarwal N; Lowrance W; Schiffman J; Kohlmann W
    Fam Cancer; 2017 Oct; 16(4):545-550. PubMed ID: 28315974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Germline genetic variants in men with prostate cancer and one or more additional cancers.
    Pilié PG; Johnson AM; Hanson KL; Dayno ME; Kapron AL; Stoffel EM; Cooney KA
    Cancer; 2017 Oct; 123(20):3925-3932. PubMed ID: 28657667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identifying patients with genetic predisposition to acute myeloid leukemia.
    Obrochta E; Godley LA
    Best Pract Res Clin Haematol; 2018 Dec; 31(4):373-378. PubMed ID: 30466750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A substantial proportion of apparently heterozygous TP53 pathogenic variants detected with a next-generation sequencing hereditary pan-cancer panel are acquired somatically.
    Coffee B; Cox HC; Bernhisel R; Manley S; Bowles K; Roa BB; Mancini-DiNardo D
    Hum Mutat; 2020 Jan; 41(1):203-211. PubMed ID: 31490007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myeloid neoplasms with germline predisposition: Practical considerations and complications in the search for new susceptibility loci.
    Carraway HE; LaFramboise T
    Best Pract Res Clin Haematol; 2020 Sep; 33(3):101191. PubMed ID: 33038980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.